Swayze Eric, EVP Research at IONIS Pharmaceuticals ($IONS), sold over $7.2 million in company shares through 13 open market transactions in the last year. His most recent sale occurred on February 13, 2026. These sales rank him 1,466th among 11,678 insiders by total value sold, below the average of $8.6 million per insider and 6.4 transactions. Eric made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | J | Common Stock | 256 | $48.87 | 32,679.0000 | 158,964,772 | 0.79% | 0.00% |
| Feb. 13, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | S | Common Stock | 9435 | $81.56 | 38,630.0000 | 158,964,772 | 19.63% | 0.01% |
| Feb. 13, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | S | Common Stock | 6207 | $82.07 | 32,423.0000 | 158,964,772 | 16.07% | 0.00% |
| Jan. 29, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | A | Common Stock | 11991 | $0.00 | 54,244.0000 | 158,964,772 | 28.38% | 0.01% |
| Jan. 30, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | S | Common Stock | 6179 | $82.93 | 48,065.0000 | 158,964,772 | 11.39% | 0.00% |
| Jan. 15, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | M | Common Stock | 21366 | $0.00 | 52,137.0000 | 158,964,772 | 69.44% | 0.01% |
| Jan. 15, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | A | Restricted Stock Unit | 225 | $0.00 | 49,537.0000 | 158,964,772 | 0.46% | 0.00% |
| Jan. 15, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | M | Restricted Stock Unit | 111 | $0.00 | 49,312.0000 | 158,964,772 | 0.22% | 0.00% |
| Jan. 15, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | A | Restricted Stock Unit | 9675 | $0.00 | 49,537.0000 | 158,964,772 | 24.27% | 0.01% |
| Jan. 15, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | M | Restricted Stock Unit | 21366 | $0.00 | 39,862.0000 | 158,964,772 | 34.90% | 0.01% |
| Jan. 15, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | A | Performance Restricted Stock Units | 25800 | $0.00 | 90,282.0000 | 158,964,772 | 40.01% | 0.02% |
| Jan. 16, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | S | Common Stock | 49 | $75.97 | 42,253.0000 | 158,964,772 | 0.12% | 0.00% |
| Jan. 15, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | M | Common Stock | 111 | $0.00 | 42,302.0000 | 158,964,772 | 0.26% | 0.00% |
| Jan. 16, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | S | Common Stock | 9884 | $75.34 | 42,253.0000 | 158,964,772 | 18.96% | 0.01% |
| Jan. 2, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | M | Non-Qualified Stock Option (right to buy) | 5125 | $0.00 | 22,553.0000 | 158,964,772 | 18.52% | 0.00% |
| Jan. 2, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | M | Non-Qualified Stock Option (right to buy) | 18338 | $0.00 | 4,215.0000 | 158,964,772 | 81.31% | 0.01% |
| Jan. 2, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | A | Non-Qualified Stock Option (right to buy) | 19350 | $0.00 | 19,500.0000 | 158,964,772 | 9999.99% | 0.01% |
| Jan. 2, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | A | Non-Qualified Stock Option (right to buy) | 150 | $0.00 | 19,500.0000 | 158,964,772 | 0.78% | 0.00% |
| Jan. 2, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | M | Common Stock | 5125 | $60.89 | 35,834.0000 | 158,964,772 | 16.69% | 0.00% |
| Jan. 2, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | S | Common Stock | 5125 | $78.57 | 30,709.0000 | 158,964,772 | 14.30% | 0.00% |
| Jan. 2, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | M | Common Stock | 18338 | $60.89 | 49,047.0000 | 158,964,772 | 59.72% | 0.01% |
| Jan. 2, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | S | Common Stock | 18338 | $79.27 | 30,709.0000 | 158,964,772 | 37.39% | 0.01% |
| Oct. 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | M | Common Stock | 125 | $0.00 | 30,762.0000 | 158,964,772 | 0.41% | 0.00% |
| Oct. 16, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | S | Common Stock | 53 | $73.62 | 30,709.0000 | 158,964,772 | 0.17% | 0.00% |
| Oct. 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | M | Restricted Stock Unit | 125 | $0.00 | 497.0000 | 158,964,772 | 20.10% | 0.00% |
| Oct. 6, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | S | Common Stock | 6849 | $69.02 | 30,637.0000 | 158,964,772 | 18.27% | 0.00% |
| Oct. 1, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | M | Common Stock | 14142 | $53.77 | 51,628.0000 | 158,964,772 | 37.73% | 0.01% |
| Oct. 2, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | M | Common Stock | 12972 | $53.77 | 50,458.0000 | 158,964,772 | 34.60% | 0.01% |
| Oct. 2, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | S | Common Stock | 12972 | $66.23 | 37,486.0000 | 158,964,772 | 25.71% | 0.01% |
| Oct. 1, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | M | Non-Qualified Stock Option (right to buy) | 14142 | $0.00 | 12,972.0000 | 158,964,772 | 52.16% | 0.01% |
| Oct. 2, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | M | Non-Qualified Stock Option (right to buy) | 12972 | $0.00 | 0.0000 | 158,964,772 | 100.00% | 0.01% |
| Oct. 1, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | S | Common Stock | 14142 | $66.09 | 37,486.0000 | 158,964,772 | 27.39% | 0.01% |
| Sept. 2, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | S | Common Stock | 10000 | $49.22 | 38,616.0000 | 158,964,772 | 20.57% | 0.01% |
| Sept. 2, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | S | Common Stock | 1130 | $53.68 | 37,486.0000 | 158,964,772 | 2.93% | 0.00% |
| Feb. 28, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | J | Common Stock | 415 | $28.21 | 48,616.0000 | 158,964,772 | 0.86% | 0.00% |
| Jan. 30, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | A | Common Stock | 3714 | $0.00 | 49,568.0000 | 0 | 8.10% | 0.00% |
| Jan. 31, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | S | Common Stock | 1367 | $32.31 | 48,201.0000 | 0 | 2.76% | 0.00% |
| Jan. 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | A | Restricted Stock Unit | 245 | $0.00 | 61,288.0000 | 0 | 0.40% | 0.00% |
| Jan. 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | M | Common Stock | 19111 | $0.00 | 53,008.0000 | 0 | 56.38% | 0.00% |
| Jan. 16, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | S | Common Stock | 7154 | $32.84 | 45,854.0000 | 0 | 13.50% | 0.00% |
| Jan. 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | M | Common Stock | 49 | $0.00 | 45,876.0000 | 0 | 0.11% | 0.00% |
| Jan. 16, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | S | Common Stock | 22 | $32.70 | 45,854.0000 | 0 | 0.05% | 0.00% |
| Jan. 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | A | Performance Restricted Stock Units | 22000 | $0.00 | 64,482.0000 | 0 | 51.79% | 0.00% |
| Jan. 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | A | Restricted Stock Unit | 33000 | $0.00 | 80,350.0000 | 0 | 69.69% | 0.00% |
| Jan. 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | M | Restricted Stock Unit | 19111 | $0.00 | 61,239.0000 | 0 | 23.78% | 0.00% |
| Jan. 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | M | Restricted Stock Unit | 49 | $0.00 | 61,239.0000 | 0 | 0.08% | 0.00% |
| Jan. 2, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | A | Non-Qualified Stock Option (right to buy) | 163 | $0.00 | 22,163.0000 | 0 | 0.74% | 0.00% |
| Jan. 2, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | A | Non-Qualified Stock Option (right to buy) | 22000 | $0.00 | 22,163.0000 | 0 | 9999.99% | 0.00% |
| Nov. 12, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | S | Common Stock | 1194 | $37.92 | 33,870.0000 | 0 | 3.41% | 0.00% |
| Oct. 16, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | S | Common Stock | 53 | $38.31 | 35,064.0000 | 0 | 0.15% | 0.00% |
| Oct. 15, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | M | Common Stock | 125 | $0.00 | 35,117.0000 | 0 | 0.36% | 0.00% |
| Oct. 15, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | M | Restricted Stock Unit | 125 | $0.00 | 426.0000 | 0 | 22.69% | 0.00% |
| Aug. 30, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | J | Common Stock | 11 | $38.64 | 34,992.0000 | 0 | 0.03% | 0.00% |
| Feb. 2, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | S | Common Stock | 1940 | $49.56 | 34,291.0000 | 0 | 5.35% | 0.00% |
| Feb. 29, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | Officer Level 14 | J | Common Stock | 605 | $34.43 | 35,014.0000 | 0 | 1.76% | 0.00% |
| Jan. 31, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | S | Common Stock | 10773 | $52.00 | 32,601.0000 | 0 | 24.84% | 0.00% |
| Feb. 1, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | A | Common Stock | 3715 | $0.00 | 36,316.0000 | 0 | 11.40% | 0.00% |
| Feb. 2, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | S | Common Stock | 1907 | $49.56 | 34,409.0000 | 0 | 5.25% | 0.00% |
| Jan. 16, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | M | Restricted Stock Unit | 17069 | $0.00 | 47,279.0000 | 0 | 26.53% | 0.00% |
| Jan. 16, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | M | Common Stock | 17069 | $0.00 | 49,670.0000 | 0 | 52.36% | 0.00% |
| Jan. 17, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | S | Common Stock | 6296 | $50.42 | 43,374.0000 | 0 | 12.68% | 0.00% |
| Jan. 16, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | M | Common Stock | 21 | $0.00 | 43,383.0000 | 0 | 0.05% | 0.00% |
| Jan. 17, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | S | Common Stock | 9 | $50.42 | 43,374.0000 | 0 | 0.02% | 0.00% |
| Jan. 16, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | M | Restricted Stock Unit | 21 | $0.00 | 47,279.0000 | 0 | 0.04% | 0.00% |
| Jan. 15, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | A | Restricted Stock Unit | 20400 | $0.00 | 64,369.0000 | 0 | 46.40% | 0.00% |
| Jan. 15, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | A | Restricted Stock Unit | 116 | $0.00 | 64,369.0000 | 0 | 0.18% | 0.00% |
| Jan. 15, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | A | Performance Restricted Stock Units | 17000 | $0.00 | 42,482.0000 | 0 | 66.71% | 0.00% |
| Jan. 2, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | A | Non-Qualified Stock Option (right to buy) | 27200 | $0.00 | 27,354.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | A | Non-Qualified Stock Option (right to buy) | 154 | $0.00 | 27,354.0000 | 0 | 0.57% | 0.00% |
| Dec. 28, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | M | Non-Qualified Stock Option (right to buy) | 27100 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 28, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | M | Common Stock | 27100 | $47.34 | 59,689.0000 | 0 | 83.16% | 0.00% |
| Dec. 28, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | S | Common Stock | 27100 | $50.19 | 32,589.0000 | 0 | 45.40% | 0.00% |
| Oct. 17, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | S | Common Stock | 52 | $47.95 | 32,589.0000 | 0 | 0.16% | 0.00% |
| Oct. 16, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | M | Restricted Stock Unit | 125 | $0.00 | 456.0000 | 0 | 21.51% | 0.00% |
| Oct. 16, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | M | Common Stock | 125 | $0.00 | 32,641.0000 | 0 | 0.38% | 0.00% |
| Feb. 28, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | J | Common Stock | 575 | $30.52 | 32,516.0000 | 0 | 1.80% | 0.00% |
| Feb. 6, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | S | Common Stock | 1815 | $40.79 | 31,941.0000 | 0 | 5.38% | 0.00% |
| Feb. 3, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | A | Common Stock | 3715 | $0.00 | 33,756.0000 | 0 | 12.37% | 0.00% |
| Jan. 17, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | M | Restricted Stock Unit | 15780 | $0.00 | 43,397.0000 | 0 | 26.67% | 0.00% |
| Jan. 18, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | S | Common Stock | 5631 | $39.74 | 30,041.0000 | 0 | 15.79% | 0.00% |
| Jan. 17, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | M | Common Stock | 15780 | $0.00 | 35,672.0000 | 0 | 79.33% | 0.00% |
| Jan. 15, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | A | Restricted Stock Unit | 81 | $0.00 | 59,758.0000 | 0 | 0.14% | 0.00% |
| Jan. 15, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | A | Restricted Stock Unit | 17207 | $0.00 | 59,758.0000 | 0 | 40.44% | 0.00% |
| Jan. 15, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | A | Performance Restricted Stock Units | 14338 | $0.00 | 25,482.0000 | 0 | 128.66% | 0.00% |
| Jan. 3, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | A | Non-Qualified Stock Option (right to buy) | 108 | $0.00 | 23,050.0000 | 0 | 0.47% | 0.00% |
| Jan. 3, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Swayze Eric | EVP Research | A | Non-Qualified Stock Option (right to buy) | 22942 | $0.00 | 23,050.0000 | 0 | 9999.99% | 0.00% |